"The PROTAC DT2216 Targets Cancer by Promoting BCL-XL Degradation."

LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

DT2216, a proteolysis-targeting chimera (PROTAC), effectively targets BCL-XLfor degradation. Click to show full abstract

DT2216, a proteolysis-targeting chimera (PROTAC), effectively targets BCL-XLfor degradation.

Keywords: protac; protac dt2216; dt2216 targets; targets cancer; degradation

Journal Title: Cancer discovery
Year Published: 2020

Link to full text (if available)

Share on Social Media: Sign Up to like & get
recommendations!
1

LAUSR

You are not signed in:

Sign Up!

Related content

More Information News Social Media Video Recommended